MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with N

Nitisinone

Nitisinone 2mg capsules

Compatible

Stability notes for Nitisinone 2mg capsules

No stability data available but no theoretical concerns with product.

Provenance

This recommendation is based on the products Nitisinone 2mg hard capsules (Logixx Pharma Ltd).

Suppliers

Nitisinone 2mg capsules (Logixx Pharma Solutions Ltd)
Orfadin 2mg capsules (Swedish Orphan Biovitrum Ltd)
Use with caution

Nitisinone 5mg capsules

Compatible

Stability notes for Nitisinone 5mg capsules

No stability data available but no theoretical concerns with product.

Provenance

This recommendation is based on the products Nitisinone 2mg, 5mg, 10mg and 20mg hard capsules (Logixx Pharma Ltd).

Suppliers

Nitisinone 5mg capsules (Logixx Pharma Solutions Ltd)
Orfadin 5mg capsules (Swedish Orphan Biovitrum Ltd)
Use with caution

Nitisinone 10mg capsules

Compatible

Stability notes for Nitisinone 10mg capsules

No stability data available but no theoretical concerns with product.

Provenance

This recommendation is based on the products Nitisinone 2mg, 5mg, 10mg and 20mg hard capsules (Logixx Pharma Ltd).

Suppliers

Nitisinone 10mg capsules (Logixx Pharma Solutions Ltd)
Orfadin 10mg capsules (Swedish Orphan Biovitrum Ltd)
Use with caution

Nitisinone 20mg capsules

Compatible

Stability notes for Nitisinone 20mg capsules

No stability data available but no theoretical concerns with product.

Provenance

This recommendation is based on the products Nitisinone 20mg hard capsules (Logixx Pharma Ltd).

Suppliers

Nitisinone 20mg capsules (Logixx Pharma Solutions Ltd)
Orfadin 20mg capsules (Swedish Orphan Biovitrum Ltd)
Use with caution

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.